High Court Turns Down Teva Unit's Provigil Patent Appeal
The U.S. Supreme Court on Monday declined to take up an appeal by a unit of Teva Pharmaceutical Industries Ltd. of a Federal Circuit finding that its patent for the narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article